rhIL-11

{
  "id": "MLC-T-ONC-007432",
  "term": "rhIL-11",
  "field": "Oncology and biomedicine",
  "definition": "A drug used to increase the number of blood cells, especially platelets, in some cancer patients receiving chemotherapy. rhIL-11 is a form of interleukin-11 (a cytokine normally made by support cells in the bone marrow) that is made in the laboratory. It is a type of biological response modifier. Also called Neumega, oprelvekin, and recombinant human interleukin-11.",
  "expansions": [
    "Neumega",
    "oprelvekin",
    "recombinant human interleukin-11"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/rhil-11/"
}